# Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants

> **NCT00580047** · NA · COMPLETED · sponsor: **University of Nebraska** · enrollment: 59 (actual)

## Conditions studied

- Renal Insufficiency

## Interventions

- **DRUG:** Zoledronic Acid
- **COMBINATION_PRODUCT:** Calcium with vitamin D
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT00580047
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12-01
- **Primary completion:** 2014-07-29
- **Final completion:** 2014-07-29
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00580047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00580047, "Effects of Zoledronic Acid Versus Alendronate on Bone Loss After Kidney and Kidney/Pancreas Transplants". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00580047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*